000 | 01939 a2200493 4500 | ||
---|---|---|---|
005 | 20250517162144.0 | ||
264 | 0 | _c20190214 | |
008 | 201902s 0 0 eng d | ||
022 | _a1475-6374 | ||
024 | 7 |
_a10.1080/14756366.2017.1334650 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGhorab, Mostafa M | |
245 | 0 | 0 |
_aVEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo[g]quinazolin bearing benzenesulfonamide moiety. _h[electronic resource] |
260 |
_bJournal of enzyme inhibition and medicinal chemistry _cDec 2017 |
||
300 |
_a893-907 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBreast _xcytology |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 | _aCatalytic Domain |
650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMCF-7 Cells |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 |
_aQuinazolines _xchemical synthesis |
650 | 0 | 4 |
_aSpectrum Analysis _xmethods |
650 | 0 | 4 |
_aSulfonamides _xchemistry |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
650 | 0 | 4 | _aBenzenesulfonamides |
700 | 1 | _aAlsaid, Mansour S | |
700 | 1 | _aSoliman, Aiten M | |
700 | 1 | _aRagab, Fatma A | |
773 | 0 |
_tJournal of enzyme inhibition and medicinal chemistry _gvol. 32 _gno. 1 _gp. 893-907 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/14756366.2017.1334650 _zAvailable from publisher's website |
999 |
_c27322760 _d27322760 |